The name resistin stands for “resistance to insulin” because it reduces the sensitivity of target tissues to insulin.
Table of contents
- Association Between Vitamin D and Resistin in Postmenopausal Females With Altered Bone Health – Jan 2021
- Serum resistin levels as predictor of low bone mineral density in postmenopausal women – 2020
- VitaminDWiki related items
- Resistin items on the web
Association Between Vitamin D and Resistin in Postmenopausal Females With Altered Bone Health – Jan 2021
Frontiers in Endocrinology published: 15 January 2021 doi: 10.3389/fendo.2020.615440
Sundus Tariq1,2*f, Saba Tariq3,4t, Saba Khaliq2ft MukhtiarBaig51, Manal Abdulaziz Murad6 and Khalid Parvez Lone 77 1 Department of Physiology, University Medical & Dental College, The University of Faisalabad, Faisalabad, Pakistan, 2 Department of Physiology and Cell Biology, University of Health Sciences, Lahore, Pakistan, 3 Department of Pharmacology and Therapeutics, University of Health Sciences, Lahore, Pakistan, 4 Pharmacology and Therapeutics, University Medical & Dental College, The University of Faisalabad, Faisalabad, Pakistan, 5 Clinical Biochemistry, Faculty of Medicine, Rabigh, King Abdulaziz University, Jeddah, Saudi Arabia, 6 Department of Family Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia,
7 Department Physiology and Cell Biology/Metabolic Disorders, University of Health Sciences, Lahore, Pakistan
Vitamin D is the only item associated with Osteoporosis
No Resistin if osteoporosis and Vitamin D > 90 ng
Background: Resistin is a relatively novel adipokine that has a role in bone remodeling and may regulat bone minera ldensity(BMD).VitaminD and adipokines ha ea dynamic role in the body's various metabolic processes, including bone metabolism, and may alter bone metabolism in relation to each other. This study aimed to investigate the association between vitamin D and serum resistin levels in postmenopausal non-osteoporotic and osteoporotic females.
Methods: This correlational analytical study was conducted on 161 postmenopausal females, divided into two groups, non-osteoporotic and osteoporotic, between 50-70 years. Bone mineral density (BMD) was assessed by dual-energy X-ray absorptiometry (DXA) scan. Serum resistin and vitamin D levels were analyzed by enzyme-linked immunosorbent assay (ELISA) method. Serum calcium, phosphate, and alkaline phosphatase with spectrophotometry. A correlation was checked using spearman’s rho correlation coefficient, and multivariate stepwise regression analysis was used to predict serum resistin levels.
Results: Postmenopausal females (n=161) having sufficient, insufficient and deficient levels of vitamin D were 87 (54.0%), 64 (39.8%), and 10 (6.2%), respectively. Lumbar spine BMD (p < 0.001), total hip BMD (p < 0.001), and serum resistin levels (p < 0.001) were significantly different between the two groups. There was a significant negative correlation between serum resistin and vitamin D in postmenopausal females (rho = -0.182, p = 0.021)and osteoporotic group (rho = -0.253, p = 0.019) but non-significant in non-osteoporotic group (rho = -0.077, p = 0.509). Serum vitamin D was found to be independent predictor of serum resistin levels, accounting for only 3% variance.
Conclusion: Serum vitamin D levels were low while serum resistin levels were high in postmenopausal osteoporotic females and vitamin D is a negative predictor of serum resistin levels.
Download the PDF from VitaminDWiki
HEALTH CARE FOR WOMEN INTERNATIONAL https://doi.org/10.1080/07399332.2020.1798965
Sundus Tariqa, g, Saba Tariqc,d, Saba Khaliq ©, and Khalid Parvez Lonee
aDepartment of Physiology, University Medical & Dental College, Faisalabad, Pakistan; bPhysiology and Cell Biology, University of Health Sciences, Lahore, Pakistan; cPharmacology and Therapeutics, University Medical & Dental College, Faisalabad, Pakistan; dPharmacology and Therapeutics, University of Health Sciences, Lahore, Pakistan; ePhysiology and Metabolic disorders, Government College
Resistin, a novel adipokine may play an important role in bone metabolism. The study is designed to discover the association of bone mineral density (BMD) with serum resistin levels, anthropometric measures and to elucidate serum resistin as a predictor of BMD in postmenopausal women. Postmenopausal women (n = 160) were recruited and divided into two groups, non-osteoporotic (n = 70) and osteoporotic (n = 90). BMD was evaluated by DXA scan. High serum resistin levels and low weight are independent contributors to low BMD and can influence BMD at lumbar spine, right femoral neck, right hip, left femoral neck, and left hip in postmenopausal women.
Osteoporosis is a skeletal disease characterized by low bone strength. Bone strength is regarded as the integration of bone density and quality. Osteoporosis is known to be a multifactorial disorder. The adipokines, released by the adipose tissue has a dynamic role in various metabolic processes of the body including the bone metabolism. Resistin, a novel adipokine may play an important role in bone metabolism, could be a predictor and new therapeutic target for osteoporosis, and can be used to reduce the risk of highly prevalent disease osteoporosis.
Osteoporosis is becoming a major health concern in developing countries (Gheita & Hammam, 2018). Osteoporosis, a disease causing the bones to become more porous and fragile due to decrease in density and quality of bone and make them more prone to fractures (Benzinger et al., 2016; International Osteoporosis Foundation, 2018). The worldwide prevalence of osteoporosis is over 200 million, with females affected more as compared to males (International Osteoporosis Foundation, 2018).
Download the PDF from VitaminDWiki
- Insulin resistance 35 percent less likely when vitamin D levels raised by 30 ng – Oct 2015
- How Vitamin D prevents Insulin Resistance – Sept 2020
- UV reduces cardiovascular and metabolic problems– Vitamin D plus Nitric oxide – Sept 2023
- Vitamin D both reduces CVD directly and reduces metabolic problems that cause CVD – May 2023
- Non-alcoholic fatty liver disease: 75 percent of overweight adults and type II diabetics – Aug 2022
- Magnesium in Obesity, Metabolic Syndrome, and Type 2 Diabetes - Jan 2021
- The Role of Magnesium in the Pathogenesis of Metabolic Disorders – April 2022
- Vitamin D might a risk factor of insulin resistance, diabetes, obesity, etc. (50 ng) – Oct 2021
- COVID-19 hospitalizations: 63% associated with diabetes, obesity, hypertension or heart failure – Feb 2021
- 26 health factors increase the risk of COVID-19 – all are proxies for low vitamin D
- 90 percent remission of recently diagnosed diabetes with a low-calorie diet
- Resveratrol improves health (Vitamin D receptor, etc.)
- Waist size reduced 3 cm by Vitamin D in those with Metabolic Syndrome – Jan 2017
- Type II Diabetes is not prevented by a small amount of vitamin D (proven again) – May 2017
- Vitamin D activates the hypothalamus (in rodents) to reduce weight and diabetes– May 2016
- Autistic child 3X more likely if mother was obese and diabetic (both associated with low vitamin D) - Feb 2015
- Diabetes is more likely if low vitamin D than if obese - Feb 2016
- Off Topic: Diabetes 11X increase for just 150 calories of sugar - June 2015
- Obese diabetics with dark skins not benefit from 6,000 IU of vitamin D daily (no surprise) – RCT March 2015
- Vitamin D3 is stored in fat has not been processed by liver – March 2015
- Diabetic hypertension reduced with Vitamin D and Calcium – RCT March 2015
- Hypothesis- Metabolic disease is due to Tissue Renin-Angiotensin Systems – Feb 2014
- Higher vitamin D at birth associated with less diabetes and obesity 35 years later – Jan 2014
- Hypothesis: Obesity causes vitamin D deficiency and type 2 diabetes - 2012
- Insulin sensitivity in obese adolescents greatly improved with 4000 IU of vitamin D - RCT April 2013
- Metabolic Syndrome 10% less likely for every 4 ng increase in Vitamin D – Jan 2013
- No association between diabetes level and vitamin D insufficiency in obese youth – Jan 2013
- African-Americans at high risk of obesity and diabetes - 2011
- Diabetes 6X more likely for those abdominal obese who have insufficient vitamin D – June 2012
- Low vitamin D associated with obesity-related diseases for ethnic minorities – Sept 2011
- Obesity lowers vitamin D which increases probability of diabetes in children – Nov 2011
- Obesity and diabetes reduced when move to better neighborhood – or better UV – Oct 2011
- Vitamin D Levels at Birth May Predict Obesity Risk at age 3 - Oct 2010
- Overview Metabolic Syndrome and vitamin D
- More obese had less vitamin D, and after low calorie diet, vitamin D went up – June 2010
- Vitamin D and Obesity from vitamin D council newsletter of Nov 2006
The Molecular Mechanisms by Which Vitamin D Prevents Insulin Resistance and Associated Disorders - Sept 2020